25 May 2013
Keywords: misrxing, cost, australia, 1b/year, inappropriate, prescribing, costing
Article | 17 March 2003
Inappropriate prescribing could be costing Australia's PharmaceuticalBenefits Scheme as much as A$1 billion ($614.6 million) a year, according to a study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.